Analyst
ICICI Securities
Equibles does not estimate personal net worth.
Abdul Kade Puranwala is recorded as Analyst at ICICI Securities. Abdul Kade Puranwala has spoken on 3 earnings calls across 3 companies, most recently for Gland Pharma Limited on November 6, 2026. Those appearances were for Gland Pharma Limited, Sun Pharmaceutical Industries Limited and Innova Captab Limited. The companies whose calls Abdul Kade Puranwala spoke on are classified in the Healthcare sector.
“First is pertaining to your current quarter and H1. So, what is the constant currency revenue”
“In terms of, you know, the outlay what we had previously talked about on the two innovative medicines for the U.S. market in terms of the marketing costs.”
“So, my first question is with regards to the Jammu facility. Now that, you know, we are talking quarterly revenues of... 85 to 90 crores. Now, should we see this as a sustainable number for quarters ahead?”
ICICI Securities
Analyst
Transcript header (unverified)
Gland Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Sun Pharmaceutical Industries Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Innova Captab Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Gland Pharma Limited
Sun Pharma Q1 FY27 Earnings Call Transcript
Sun Pharmaceutical Industries Limited
“Innova Captab Limited Q3 & 9M FY26 Earnings Conference Call”
Innova Captab Limited
